Clinical trials
Artificial Intelligence (AI) in Diagnosis clinical trials
Below are recruiting artificial intelligence (ai) in diagnosis clinical trials, each written for real people, not researchers. We’re tracking 68 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07471984Enrolling by invitation
Checking how AI reads brain scans for better diagnosis
This study tests a new AI tool to see if it can help doctors better understand brain MRI and CT scans. It may find issues like strokes, bleeding, tumors, or injuries.
BeijingAges Any age - NCT06968533Enrolling by invitation
AI ECG for detecting low heart pumping in older adults
This trial uses an AI tool to analyze your ECG (heart tracing) to detect low pumping function. It may help find hidden heart issues early, especially if you haven't had a recent heart ultrasound.
TaipeiAges 60–85 - NCT06957678Enrolling by invitation
AI predicts lymph node spread in stomach cancer using scans and biopsy
This study uses artificial intelligence to predict whether stomach cancer has spread to nearby lymph nodes. By analyzing your CT/MRI scans and biopsy results before surgery, the AI may help doctors plan your treatment more precisely.
Shijiazhuang, None SelectedAges 18–80 - NCT06931782Enrolling by invitation
AI for respiratory disease screening study
This trial tests whether an artificial intelligence (AI) tool can help prevent, diagnose, and triage respiratory diseases. It is open to adults without medical training who can follow a survey.
Guangzhou, GuangdongAges 18–75 - NCT05704491Recruiting
AI screening for diabetic eye damage
This study tests an artificial intelligence (AI) screening method to detect diabetic retinopathy, a type of eye damage caused by diabetes. It may help find eye changes earlier, so treatment can be planned sooner.
DüsseldorfAges 18 years+ - NCT06847932Recruiting
AI ECG to detect early atrial fibrillation
This trial uses an artificial intelligence system to analyze your electrocardiogram (ECG) results and alert your care team if you might be developing atrial fibrillation. It aims to catch this common heart rhythm problem early, so you can get treatment sooner.
TaipeiAges 1 month–3 months - NCT06824909Recruiting
Faster pancreas tumor diagnosis with AI
This trial uses a new, faster method to diagnose solid pancreatic tumors during an endoscopic ultrasound procedure. It combines rapid staining of cells with artificial intelligence to give a quick and accurate diagnosis.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06864702Enrolling by invitation
AI tool to analyze medical images for liver surgery patients
This trial is testing a computer program that can automatically analyze medical images like CT scans from people who have had laparoscopic liver, gallbladder, or pancreas surgery. The goal is to see if the AI can help doctors better plan and perform these surgeries.
Guangzhou, GuangdongAges 18–85 - NCT06766422Recruiting
AI tool to better detect and predict brain aneurysm risk
This study uses artificial intelligence to help doctors better see and understand brain aneurysms from MRI or CT scans. It aims to improve how accurately aneurysms are found and whether they are stable or at risk of rupturing.
ShanghaiAges 18 years+ - NCT07469215Recruiting
Parent training with AI support for child behavior issues
This study tests a parent training program for children aged 5–12 with disruptive behaviors. Some parents will also get AI support. The goal is to see if AI helps improve the training's effects.
Barcelona, BarcelonaAges 5–12 - NCT06767111Enrolling by invitation
Techcyte SureView cervical cytology system validation study
This study is testing a new computer system (Techcyte SureView) that helps doctors read Pap test slides. If you have a glass slide from a previous Pap test that meets the requirements, your slide could be used to help validate this system.
Orem, UtahAges 18 years+ - NCT06587126Recruiting
Can a Cough Monitor Work in Children?
This study tests a way to monitor coughing in children at home, including children with cystic fibrosis and healthy children. It will help researchers learn how well a cough monitor works in real life.
Aurora, ColoradoAges 1–18 - NCT07715617Recruiting
Creating a prediction score for lung transplant or death in Alpha-1 Antitrypsin Deficiency
This study is creating a simple scoring system to predict who with Alpha-1 Antitrypsin Deficiency-related emphysema might need a lung transplant or die from the disease. Your medical records from 2010–2025 will help build this tool, with no extra tests or visits required.
BronAges 18 years+ - NCT04763980Recruiting
Health coaching to help Black men get prostate germline genetic testing
This study tests a community health coach to help Black men with prostate cancer understand and access genetic testing that looks for inherited cancer risk. It may help you talk with your care team about testing and reduce barriers to getting results.
San Francisco, CaliforniaAges 18 years+ - NCT05389774Recruiting
Testing an AI tool that predicts lung cancer risk from CT scans
This study tests whether Optellum’s AI prediction tool can better identify which lung nodules found on CT scans are more likely to be cancer. You may be asked to provide specific types of CT images so the tool can be evaluated.
BangorAges 35 years+ - NCT07236840Recruiting
Remote neurological exams via smartphone for brain tumor patients
This trial tests if a smartphone app can help patients or caregivers perform a neurological exam at home. It aims to make check-ups easier for people with brain tumors.
Mumbai, MaharashtraAges 5 years+ - NCT07237607Recruiting
AI chatbot for teens and young adults with eating disorders
This trial is testing a new AI chatbot to support teens and young adults with eating disorders. If you are in an outpatient program at Penn State Health, the chatbot might help you manage your recovery.
Hershey, PennsylvaniaAges 12–26 - NCT07059923Recruiting
Predicting immunotherapy response in lung cancer with AI and radiology
This study uses artificial intelligence and CT scan analysis to predict how well lung cancer patients will respond to immunotherapy. It may help doctors choose the best treatment for you.
Wuhan, HubeiAges 18 years+ - NCT06286267Recruiting
AI tool for diagnosing breast phyllodes tumors
This trial uses an artificial intelligence system to help doctors more accurately diagnose and predict the outcome of breast phyllodes tumors, which are rare breast growths. It aims to improve how these tumors are identified and managed.
Guangzhou, GuangdongAges Any age - NCT07439757Recruiting
Using AI to Guide Care for Pancreatic Conditions
This study uses artificial intelligence (AI) to help doctors make better decisions for people with suspected pancreatic conditions. If you are already getting a special CT scan, the AI will analyze the images to see if it can improve diagnosis and treatment planning.
ShanghaiAges 18–80 - NCT06360523Recruiting
AI-guided MRI for prostate cancer diagnosis
This trial tests if an artificial intelligence system can improve MRI scans used to detect prostate cancer. You may join if your doctor has recommended a prostate biopsy and you have an MRI scan that can be reviewed by both radiologists and AI.
Hong KongAges 18 years+ - NCT05959746Recruiting
AI video tool study for early stroke and TIA diagnosis
This study collects short video and clinical information from people being checked for stroke or a “mini-stroke” (TIA) soon after symptoms start, to help build an AI diagnostic tool. You may be contacted again for a follow-up visit within about 4 months.
Nîmes, GardAges 18 years+ - NCT07059936Recruiting
AI and scans to predict immunotherapy response in liver cancer
This study uses artificial intelligence (AI) to analyze your CT or MRI scans and help predict how well immunotherapy might work for your liver cancer. The goal is to find better ways to match you with the right treatment and improve your outcomes.
Wuhan, HubeiAges 18 years+ - NCT06392737Recruiting
AI-guided MRI vs routine MRI for prostate biopsy
This study tests whether an artificial intelligence tool for MRI can improve the results of targeted prostate biopsy, compared to the usual method. It could help diagnose prostate cancer more accurately with fewer needles.
Beijing, Beijing MunicipalityAges 45–85
Hear when a new Artificial Intelligence (AI) in Diagnosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for artificial intelligence (ai) in diagnosis?
- Yes. Clin2 currently lists 68 recruiting artificial intelligence (ai) in diagnosis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a artificial intelligence (ai) in diagnosis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a artificial intelligence (ai) in diagnosis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.